Search research articles
Contact Us
Filters
Showing results (141-150 of 620) with videos related to
Page
of 62
Sort By:
Neurology
|
April 23, 2008
Acute treatment and prevention of menstrually related migraine headache: evidence-based review
Tamara Pringsheim, William Jeptha Davenport, David Dodick
Headache
|
September 24, 2005
Removing barriers to appropriate migraine treatment: formulary limitations and triptan package size
Stephen D Silberstein, David Dodick, Jim Kesslick
Current Pain and Headache Reports
|
May 17, 2007
Patent foramen ovale and migraine
Hans-Christoph Diener, Tobias Kurth, David Dodick
CNS Drugs
|
December 28, 2006
Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine
David W Dodick, Giorgio Sandrini, Paul Williams
Current Pain and Headache Reports
|
November 17, 2010
Treatment of chronic migraine
Hans-Christoph Diener, Dagny Holle, David Dodick
The Laryngoscope
|
September 13, 2014
Comprehensive management of patients presenting to the otolaryngologist for sinus pressure, pain, or headache
Devyani Lal, Alexis Rounds, David W Dodick
The Journal of Headache and Pain
|
April 5, 2011
Reply: Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine
Sheena Aurora, Hans-Christoph Diener, David Dodick, et al.
Seminars in Neurology
|
March 31, 2010
Cluster headache: diagnosis and treatment
Rashmi Halker, Bert Vargas, David W Dodick
Current Opinion in Neurology
|
May 15, 2007
Patent foramen ovale, stroke, and cardiovascular disease in migraine
Hans-Christoph Diener, Tobias Kurth, David Dodick
Headache
|
October 21, 2010
Defining the pharmacologically intractable headache for clinical trials and clinical practice
Stephen D Silberstein, David W Dodick, Starr Pearlman
Page
of 62
Search research articles
Search
Showing results (141-150 of 620) with videos related to
Sort By:
Page
of 62
Neurology
|
April 23, 2008
Acute treatment and prevention of menstrually related migraine headache: evidence-based review
Tamara Pringsheim, William Jeptha Davenport, David Dodick
Headache
|
September 24, 2005
Removing barriers to appropriate migraine treatment: formulary limitations and triptan package size
Stephen D Silberstein, David Dodick, Jim Kesslick
Current Pain and Headache Reports
|
May 17, 2007
Patent foramen ovale and migraine
Hans-Christoph Diener, Tobias Kurth, David Dodick
CNS Drugs
|
December 28, 2006
Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine
David W Dodick, Giorgio Sandrini, Paul Williams
Current Pain and Headache Reports
|
November 17, 2010
Treatment of chronic migraine
Hans-Christoph Diener, Dagny Holle, David Dodick
The Laryngoscope
|
September 13, 2014
Comprehensive management of patients presenting to the otolaryngologist for sinus pressure, pain, or headache
Devyani Lal, Alexis Rounds, David W Dodick
The Journal of Headache and Pain
|
April 5, 2011
Reply: Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine
Sheena Aurora, Hans-Christoph Diener, David Dodick, et al.
Seminars in Neurology
|
March 31, 2010
Cluster headache: diagnosis and treatment
Rashmi Halker, Bert Vargas, David W Dodick
Current Opinion in Neurology
|
May 15, 2007
Patent foramen ovale, stroke, and cardiovascular disease in migraine
Hans-Christoph Diener, Tobias Kurth, David Dodick
Headache
|
October 21, 2010
Defining the pharmacologically intractable headache for clinical trials and clinical practice
Stephen D Silberstein, David W Dodick, Starr Pearlman
Page
of 62